Margaret Beliveau

Learn More
PURPOSE We studied the safety, tolerability, and recommended dose of BMS-599626, an orally bioavailable inhibitor of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases. PATIENTS AND METHODS Patients with advanced solid tumors that expressed epidermal growth factor receptor (EGFR) and/or HER-2 were recruited and enrolled(More)
Bacille Calmette-Guerin vaccine–induced disease in HIV-infected and HIV-uninfect-ed children. et al. Danish bacille Calmette-Guerin vaccine–induced disease in human im-munodeficiency virus–infected children.tection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl(More)
OBJECTIVE To compare the quality of referrals of patients with complex medical problems from nurse practitioners (NPs), physician assistants (PAs), and physicians to general internists. PATIENTS AND METHODS We conducted a retrospective comparison study involving regional referrals to an academic medical center from January 1, 2009, through December 31,(More)
Introduction BTH1677, a 1,3–1,6 beta-glucan immunomodulator, stimulates a coordinated anti-cancer immune response in combination with anti-tumor antibody therapies. This phase II study explored the efficacy, pharmacokinetics (PK), and safety of BTH1677 combined with cetuximab/carboplatin/paclitaxel in untreated stage IIIB/IV non-small cell lung cancer(More)
  • 1